31st Jan 2014 07:57
LONDON (Alliance News) - Drug company Skyepharma PLC Friday said said it expects to report 2013 revenues and operating profits that are materially ahead of market expectations.
In a statement, the specialist in oral and inhaled drugs, said a number of items need to be finalised, including receipt of royalty statements for the fourth quarter, but it already expects to beat expectations.
By Steve McGrath; [email protected]; @SteveMcGrath1
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
SKP.L